Pfizer To Buy Global Blood Therapeutics In $Five Four Billion Deal
The B.1.1.7 variant now dominates in the UK and these benefits will largely reflect vaccine effectiveness against this variant. The investigators identified 94,354 vaccine recipients and matched them to 94,354 unvaccinated controls baseline demographic and clinical traits have been equivalent involving the two groups. In this evaluation,...